MENON, Bijoy K., Fahad S. AL-AJLAN, Mohamed NAJM, Josep PUIG, Mar CASTELLANOS, Dar DOWLATSHAHI, Ana CALLEJA, Sung Il SOHN, Seong H. AHN, Alex POPPE, Robert MIKULÍK, Negar ASDAGHI, Thalia S. FIELD, Albert JIN, Talip ASIL, Jean Martin BOULANGER, Eric E. SMITH, Shelag B. COUTTS, Phil A. BARBER, Simerpreet BAL, Suresh SUBRAMANIAN, Sachin MISHRA, Anurag TRIVEDI, Sadanand DEY, Muneer EESA, Tolulope SAJOBI, Mayank GOYAL, Michael D. HILL and Andrew M. DEMCHUK. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke. JAMA-Journal of the American Medical Association. Chicago, USA: American Medical Association, 2018, vol. 320, No 10, p. 1017-1026. ISSN 0098-7484. Available from: https://dx.doi.org/10.1001/jama.2018.12498.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke
Authors MENON, Bijoy K. (124 Canada), Fahad S. AL-AJLAN (682 Saudi Arabia), Mohamed NAJM (724 Spain), Josep PUIG (724 Spain), Mar CASTELLANOS (724 Spain), Dar DOWLATSHAHI (124 Canada), Ana CALLEJA (724 Spain), Sung Il SOHN (410 Republic of Korea), Seong H. AHN (410 Republic of Korea), Alex POPPE (124 Canada), Robert MIKULÍK (203 Czech Republic, belonging to the institution), Negar ASDAGHI (840 United States of America), Thalia S. FIELD (124 Canada), Albert JIN (124 Canada), Talip ASIL (792 Turkey), Jean Martin BOULANGER (124 Canada), Eric E. SMITH (124 Canada), Shelag B. COUTTS (124 Canada), Phil A. BARBER (124 Canada), Simerpreet BAL (124 Canada), Suresh SUBRAMANIAN (124 Canada), Sachin MISHRA (36 Australia), Anurag TRIVEDI (124 Canada), Sadanand DEY (124 Canada), Muneer EESA (124 Canada), Tolulope SAJOBI (124 Canada), Mayank GOYAL (124 Canada), Michael D. HILL (124 Canada) and Andrew M. DEMCHUK (124 Canada, guarantor).
Edition JAMA-Journal of the American Medical Association, Chicago, USA, American Medical Association, 2018, 0098-7484.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 51.273
RIV identification code RIV/00216224:14110/18:00105510
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1001/jama.2018.12498
UT WoS 000444341400015
Keywords in English Acute Ischemic Stroke
Tags 14110127, rivok
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 9/2/2019 20:44.
Abstract
IMPORTANCE Recanalization of intracranial thrombus is associated with improved clinical outcome in patients with acute ischemic stroke. The association of intravenous alteplase treatment and thrombus characteristics with recanalization over time is important for stroke triage and future trial design. OBJECTIVE To examine recanalization over time across a range of intracranial thrombus occlusion sites and clinical and imaging characteristics in patients with ischemic stroke treated with intravenous alteplase or not treated with alteplase. DESIGN, SETTING, AND PARTICIPANTS Multicenter prospective cohort study of 575 patients from 12 centers (in Canada, Spain, South Korea, the Czech Republic, and Turkey) with acute ischemic stroke and intracranial arterial occlusion demonstrated on computed tomographic angiography (CTA). EXPOSURES Demographics, clinical characteristics, time from alteplase to recanalization, and intracranial thrombus characteristics (location and permeability) defined on CTA. MAIN OUTCOMES AND MEASURES Recanalization on repeat CTA or on first angiographic acquisition of affected intracranial circulation obtained within 6 hours of baseline CTA, defined using the revised arterial occlusion scale (rAOL) (scores from 0 [primary occlusive lesion remains the same] to 3 [complete revascularization of primary occlusion]). RESULTS Among 575 patients (median age, 72 years [IQR, 63-80]; 51.5% men; median time from patient last known well to baseline CTA of 114 minutes [IQR, 74-180]), 275 patients (47.8%) received intravenous alteplase only, 195 (33.9%) received intravenous alteplase plus endovascular thrombectomy, 48 (8.3%) received endovascular thrombectomy alone, and 57 (9.9%) received conservative treatment. Median time from baseline CTA to recanalization assessment was 158 minutes (IQR, 79-268); median time from intravenous alteplase start to recanalization assessment was 132.5 minutes (IQR, 62-238). Successful recanalization occurred at an unadjusted rate of 27.3%(157/575) overall, including in 30.4%(143/470) of patients who received intravenous alteplase and 13.3%(14/105) who did not (difference, 17.1%[95% CI, 10.2%-25.8%]). Among patients receiving alteplase, the following factors were associated with recanalization: time from treatment start to recanalization assessment (OR, 1.28 for every 30-minute increase in time [95% CI, 1.18-1.38]), more distal thrombus location, eg, distal M1 middle cerebral artery (39/84 [46.4%]) vs internal carotid artery (10/92 [10.9%]) (OR, 5.61 [95% CI, 2.38-13.26]), and higher residual flow (thrombus permeability) grade, eg, hairline streak (30/45 [66.7%]) vs none (91/377 [24.1%]) (OR, 7.03 [95% CI, 3.32-14.87]). CONCLUSIONS AND RELEVANCE In patients with acute ischemic stroke, more distal thrombus location, greater thrombus permeability, and longer time to recanalization assessment were associated with recanalization of arterial occlusion after administration of intravenous alteplase; among patients who did not receive alteplase, rates of arterial recanalization were low. These findings may help inform treatment and triage decisions in patients with acute ischemic stroke.
PrintDisplayed: 20/8/2024 07:19